Olivo Alicia C

EVP, GC & Business Development

Olivo Alicia C has filed 8 SEC Form 4 filings (14 transaction rows) across 1 company, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Sep 3, 2026.

On the most recent filing, Olivo Alicia C is listed as EVP, GC & Business Development at NEOGENOMICS INC. Inside the rolling window, Olivo Alicia C reported no open-market purchases and 2 open-market sales totaling $300K in NEO. The largest disclosed transaction in the window is a sale of 20,916 NEO shares on Nov 25, 2025, worth $251K.

Companies traded

Other insiders at NEO

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$300K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
NEOSale$251KNov 28SEC ↗
NEOSale$49KOct 20SEC ↗
Showing 1–2 of 2
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Olivo Alicia C made?

Olivo Alicia C has filed 8 SEC Form 4 filings (14 transaction rows) across 1 company since 2025.

Which companies does Olivo Alicia C trade?

Olivo Alicia C has filed SEC Form 4 disclosures for 1 company, including NEO.

When was Olivo Alicia C's most recent SEC Form 4 filing?

Olivo Alicia C's most recent SEC Form 4 filing on Tracefour is dated Sep 3, 2026.

What is Olivo Alicia C's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Olivo Alicia C is listed as EVP, GC & Business Development.

What is Olivo Alicia C's total buy and sell value in the current window?

Inside the rolling retention window, Olivo Alicia C bought $0 and sold $300K based on SEC Form 4 filings.

What was Olivo Alicia C's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 20,916 NEO shares on 2025-11-25, worth $251K, per SEC Form 4 filings.